Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-22

Clinical Trial Update: Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Biafine Cream to reduce radiation side effects in advanced head and neck cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biafine Cream

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy | Phase 3 | Status: COMPLETED